Table 1 Baseline characteristics of the MAFLD group and non-MAFLD group.
Characteristic | Total (n = 1164) | MAFLD (n = 680) | Non-MAFLD (n = 484) | t/z/χ2 | P |
|---|---|---|---|---|---|
Male | 606 (52%) | 363 (53.38%) | 243 (50.20%) | 1.14 | 0.280 |
Age | 60.68 ± 10.32 | 60.77 ± 10.51 | 60.56 ± 10.05 | 0.34 | 0.710 |
BMI | 24.92 ± 3.87 | 26.30 ± 3.59 | 22.98 ± 3.38 | 15.92 | 0.000 |
Systolic BP | 126.90 ± 16.19 | 129.28 ± 16.06 | 123.57 ± 15.82 | 0.84 | 0.000 |
Diastolic BP | 78.04 ± 11.31 | 79.38 ± 11.21 | 76.17 ± 11.20 | 0.79 | 0.000 |
Type 2 diabetes | 345 (29.64%) | 258 (37.94%) | 87 (12.79%) | 54.05 | 0.000 |
Hypertension | 732 (62.80) | 487 (71.62%) | 245 (50.41%) | 53.42 | 0.000 |
Smoking | 324 (27.84%) | 196 (28.82%) | 128 (26.45%) | 16.05 | 0.372 |
Obesity | 214 (18.38%) | 183 (26.75%) | 31 (6.4%) | 79.24 | 0.000 |
Lipid-lowering drugs | 894 (76.80%) | 553 (81.32%) | 341 (70.45%) | 18.75 | 0.000 |
Hyperlipidemia | 674 (57.90%) | 465 (68.38%) | 275 (56.81%) | 16.33 | 0.000 |
TG | 2.04 ± 1.79 | 2.41 ± 2.13 | 1.51 ± 0.93 | -11.76 | 0.000 |
HDL | 1.13 ± 0.30 | 1.08 ± 0.26 | 1.20 ± 0.33 | -6.36 | 0.000 |
LDL | 2.90 ± 0.95 | 2.93 ± 0.92 | 2.86 ± 0.88 | -3.21 | 0.158 |
FBG | 6.18 ± 2.39 | 6.48 ± 2.47 | 5.76 ± 2.20 | -7.33 | 0.000 |
ALT | 26.71 ± 21.96 | 28.77 ± 22.20 | 23.82 ± 21.31 | -7.52 | 0.000 |
AST | 25.63 ± 25.75 | 25.55 ± 24.16 | 25.74 ± 27.84 | -1.11 | 0.900 |
Creatinine | 75.04 ± 31.47 | 74.95 ± 28.98 | 75.17 ± 34.69 | -1.01 | 0.314 |
Urea | 5.68 ± 2.50 | 5.53 ± 1.88 | 5.90 ± 3.16 | -1.26 | 0.207 |
Uric acid | 385.44 ± 106.02 | 405.60 ± 98.42 | 357.11 ± 109.87 | -7.98 | 0.000 |
